GEODE CAPITAL MANAGEMENT, LLC - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$107,135
-41.5%
411,922
+8.8%
0.00%
Q2 2023$183,085
-26.6%
378,6670.0%0.00%
Q1 2023$249,579
+59323.6%
378,6670.0%0.00%
Q4 2022$420
-99.8%
378,667
+18.1%
0.00%
Q3 2022$237,000
+28.1%
320,627
+4.0%
0.00%
Q2 2022$185,000
-74.3%
308,432
+5.0%
0.00%
Q1 2022$719,000
-28.8%
293,867
+38.9%
0.00%
Q4 2021$1,010,000
+138.2%
211,500
+362.1%
0.00%
Q3 2021$424,000
+6.0%
45,766
+32.8%
0.00%
Q2 2021$400,00034,4750.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Texas Capital Bank Wealth Management Services Inc 63,290$41,7140.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 230,700$152,0540.00%
Virtu Financial LLC 46,210$300.00%
United Asset Strategies, Inc. 18,300$12,0620.00%
HBK Sorce Advisory LLC 29,230$19,2660.00%
UBS Group AG 18,611$12,2650.00%
NewEdge Advisors, LLC 2,125$1,4010.00%
OSAIC HOLDINGS, INC. 27,225$17,9330.00%
BANK OF AMERICA CORP /DE/ 30,000$19,7700.00%
WELLS FARGO & COMPANY/MN 5,309$3,5000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders